BREAKINGON
obesity treatment search result
Bariatric Surgery Beats GLP-1 Medications in Weight Loss: New Study Reveals Shocking Results

Bariatric Surgery Beats GLP-1 Medications in Weight Loss: New Study Reveals Shocking Results

HEALTH - 6/17/2025

A groundbreaking study shows that bariatric surgery leads to five times more weight loss than GLP-1 drugs like semaglutide. Discover why surgery remains the gold standard in obesity treatment.

Regulator Confirms Ozempic Linked to Rare Blindness Risk: What You Need to Know

Regulator Confirms Ozempic Linked to Rare Blindness Risk: What You Need to Know

HEALTH - 6/7/2025

A new regulator confirmation links Ozempic to a rare eye condition, NAION, affecting diabetes patients. This revelation raises concerns about potential blindness risks associated with semaglutide. Discover the implications for users.

Groundbreaking Study Reveals Why GLP-1 Medications Work Better for Women

Groundbreaking Study Reveals Why GLP-1 Medications Work Better for Women

HEALTH - 5/18/2025

Recent clinical trials show that GLP-1 weight loss medications like Zepbound are more effective for women than men, prompting researchers to explore the biological and societal reasons behind this phenomenon.

Mounjaro vs Ozempic: The Ultimate Showdown in Weight Loss Jabs

Mounjaro vs Ozempic: The Ultimate Showdown in Weight Loss Jabs

HEALTH - 5/15/2025

In a groundbreaking clinical trial, Mounjaro proves to be nearly 50% more effective than Ozempic. This article explores the implications of this major breakthrough in weight loss treatments.

Mounjaro Outshines Wegovy in Major Weight-Loss Drug Trial

Mounjaro Outshines Wegovy in Major Weight-Loss Drug Trial

HEALTH - 5/12/2025

A groundbreaking trial reveals that Mounjaro is more effective than Wegovy for weight loss, achieving a 20% reduction over 72 weeks compared to Wegovy's 14%. Discover the implications for obesity treatment!

Semaglutide: A Breakthrough in Treating Fatty Liver Disease

Semaglutide: A Breakthrough in Treating Fatty Liver Disease

HEALTH - 5/2/2025

A groundbreaking study reveals semaglutide, already known for weight loss and diabetes treatment, is effective for fatty liver disease, benefiting two-thirds of participants in a recent trial. This could revolutionize treatment options!

Eli Lilly Launches Cheaper Doses of Weight Loss Drug Zepbound for Uninsured Patients

Eli Lilly Launches Cheaper Doses of Weight Loss Drug Zepbound for Uninsured Patients

HEALTH - 2/25/2025

Eli Lilly introduces discounted higher doses of the weight loss drug Zepbound in a move to make the treatment more accessible to uninsured patients and address the growing demand for obesity treatments.

Breakingon.com is an independent news platform that delivers the latest news, trends, and analyses quickly and objectively. We gather and present the most important developments from around the world and local sources with accuracy and reliability. Our goal is to provide our readers with factual, unbiased, and comprehensive news content, making information easily accessible. Stay informed with us!
© Copyright 2025 BreakingOn. All rights reserved.